← FDA Drug Approvals (Drugs@FDA)
DROSPIRENONE
NDA · New Drug Application · Sponsor: EXELTIS USA INC · Approved 2022-06-29
Drug application
- FDA Application #
NDA216285- Application type
- New Drug Application
- Brand name
- DROSPIRENONE
- Generic name
- Drospirenone
- Active ingredients
- DROSPIRENONE
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- EXELTIS USA INC
- First approval
- 2022-06-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown